Healthcare / Health Information ServicesTokyo
$613.00
-19.00 (-3.01%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 16%
FCF escenarios
weak_data · normalized FCF $-177.9M · quality 38.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
17/100
F
Piotroski
1/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$10.3B
P/E
N/A
•EV/EBITDA
N/A
•ROE
-7.8%
↓Gross Margin
96.6%
↑Debt/Equity
N/A
•TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2024 · 3 años de histórico normalizado
Revenue CAGR
+43.7%
FCF CAGR
—
FCF margin
-70.1%
FCF / Net income
0.67x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $342.6M · net income $-357.4M · FCF $-240.0M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $342.6M | $342.6M | $530.7M | $316.9M | $115.5M |
| Net Income | $-357.4M | $-357.4M | $-50.7M | $-233.5M | $-277.6M |
| EBITDA | $-359.0M | $-359.0M | $-42.8M | $-227.1M | $-333.3M |
| EPS | -21.41 | -21.41 | -3.09 | -15.90 | — |
| Gross Margin | 96.6% | 96.6% | 98.5% | 96.7% | 91.5% |
| Operating Margin | -106.5% | -106.5% | -9.1% | -72.3% | -288.7% |
| Net Margin | -104.3% | -104.3% | -9.6% | -73.7% | -240.3% |
| Balance Sheet | |||||
| Current Ratio | 35.40 | 35.40 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-240.0M | $-240.0M | $82.4M | $-177.9M | $-239.5M |
| Returns | |||||
| ROE | -7.8% | -7.8% | -1.0% | -4.8% | -17.6% |
| Valuation | |||||
| P/B | 2.22 | 2.22 | 5.59 | 2.98 | — |
| Growth & Yield | |||||
| Revenue Growth | -35.4% | -35.4% | 67.5% | 174.4% | — |
| EPS Growth | -592.9% | -592.9% | 80.6% | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+4.8%
Start / end P/E
n/dx → n/dx
EPS bridge
-3.09 → -21.41
Residual
+4.8%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.